EVOKE PHARMA INC (EVOK) Stock Balance Sheet
NASDAQ:EVOK - Nasdaq - US30049G3020 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 13.60M | 4.74M | 9.84M | 9.14M | 8.07M | |||
| Receivables | 2.42M | 673.10K | 620.00K | 300.00K | 20.00K | |||
| Inventories | 445.10K | 481.80K | 290.00K | 190.00K | 240.00K | |||
| Other Current Assets | 775.90K | 932.60K | 960.00K | 930.00K | 950.00K | |||
| Total Current Assets | 17.24M | 6.83M | 11.72M | 10.56M | 9.28M | |||
| Non-Current Assets | ||||||||
| PPE Net | 154.20K | 0.00 | 130.00K | 10.00K | 140.00K | |||
| Other Non-Current Assets | 126.90K | 241.60K | N/A | 0.00 | 10.00K | |||
| Total Non-Current Assets | 281.10K | 241.70K | 130.00K | 10.00K | 150.00K | |||
| TOTAL ASSETS | 17.52M | 7.07M | 11.85M | 10.57M | 9.43M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 5.00M | 0.00 | 0.00 | 0.00 | 100.00K | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 3.04M | 1.32M | 720.00K | 530.00K | 1.16M | |||
| Accounts Payable | 2.34M | 1.71M | 930.00K | 870.00K | 1.27M | |||
| Other Current Liabilities | N/A | N/A | N/A | 0.00 | 5.00M | |||
| Total Current Liabilities | 10.38M | 3.04M | 1.65M | 1.41M | 7.54M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 5.00M | 5.00M | 5.00M | 5.00M | |||
| Other Non-Current Liabilities | 101.00K | 1.61M | 1.11M | 610.00K | 110.00K | |||
| Total Non-Current Liabilities | 101.00K | 6.61M | 6.12M | 5.61M | 5.11M | |||
| TOTAL LIABILITIES | 10.48M | 9.65M | 7.77M | 7.02M | 12.65M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -128.79M | -123.44M | -115.65M | -107.42M | -98.89M | |||
| Additional Paid In Capital | 135.83M | 120.86M | 119.73M | 110.97M | 95.67M | |||
| Common Shares | 100.00 | 300.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 1.49M | 278.60K | 3.34M | 2.72M | 2.22M | |||
| Tangible Book Value per Share | 4.74 | -9.26 | 1.22 | 1.31 | -1.45 | |||
| Total Shareholders' Equity | 7.04M | -2.58M | 4.08M | 3.56M | -3.21M | |||
| TOTAL LIABILITIES AND EQUITY | 17.52M | 7.07M | 11.85M | 10.57M | 9.43M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | -1.94 | 1.23 | 1.40 | -1.59 | |||
| Current Ratio | 1.66 | 2.25 | 7.10 | 7.49 | 1.23 | |||
| Return On Assets (ROA) | -30.55% | -110.24% | -69.37% | -80.79% | -139.45% | |||
| Return On Equity (ROE) | -76.05% | N/A | -201.47% | -239.89% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21